Clinical Trials Logo

Clinical Trial Summary

In clinical practice language impairment is frequently reported in association with nocturnal epileptiform activity. There is a spectrum of epileptic conditions that are characterized by nocturnal epileptiform activity. From mild to severe this spectrum involves: Rolandic epilepsy (RE), nocturnal frontal lobe epilepsy (NFLE), Landau-Kleffner syndrome (LKS) and electrical status epilepticus during slow wave sleep (ESES). The exact characteristic of the relationship between nocturnal epileptiform activity and language impairment is yet to be explored. The investigators suggest that nocturnal epileptiform EEG discharges and nocturnal epileptic seizures during development will cause diseased neuronal networks that involve language. The diseased neuronal networks are less efficient compared with normal neuronal networks.

Objective: Identification of a diseased neuronal network characteristic in children with nocturnal epileptiform activity, which can explain language impairment in these children. For this the investigators will use functional magnetic resonance imaging (MRI) to analyse brain activity and diffusion weighted MRI to investigate white matter connectivity.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT01335425
Study type Observational
Source Maastricht University Medical Center
Contact
Status Completed
Phase N/A
Start date October 2010
Completion date December 2013

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01046760 - Scholar Performance and Praxis Assessment in Children With Rolandic Epilepsy N/A
Completed NCT03547050 - Rolandic Epilepsy Genomewide Association International Study
Recruiting NCT04569708 - Sleep Spindles and Memory in Rolandic Epilepsy N/A
Completed NCT01515436 - The Effect of Music Periodicity on Interictal Epileptiform Discharges N/A
Terminated NCT04610879 - Changing Agendas on Sleep, Treatment and Learning in Epilepsy Phase 4